Q4 2015 13F Holders as of 31 Dec 2015
-
Type / Class
-
Equity / Common Stock, $0.00001 par value per share
-
Shares outstanding
-
189,947,836
-
Total 13F shares
-
13,788,837
-
Share change
-
+12,378,148
-
Total reported value
-
$218,726,000
-
Price per share
-
$15.95
-
Number of holders
-
18
-
Value change
-
+$196,226,000
-
Number of buys
-
17
Institutional Holders of Wave Life Sciences Ltd. - Common Stock, $0.00001 par value per share (WVE) as of Q4 2015
As of 31 Dec 2015,
Wave Life Sciences Ltd. - Common Stock, $0.00001 par value per share (WVE) was held by
18 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
13,788,837 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, LLC, FMR LLC, Foresite Capital Management III, LLC, Redmile Group, LLC, New Leaf Venture Partners, L.L.C., Clough Capital Partners L P, Cormorant Asset Management, LLC, JENNISON ASSOCIATES LLC, GEODE CAPITAL MANAGEMENT, LLC, and GOLDMAN SACHS GROUP INC.
This page lists
18
institutional shareholders reporting positions in this security
for the Q4 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.